FDA Vaccines & Related Biological Products Advisory Committee
Executive Summary
Will meet June 7 to address clinical development and design of trials for vaccines for prevention of Lyme disease during an open session from 8 a.m. to 1 p.m. Committee deliberations will be closed from I p.m. to 6 p.m. for review of confidential information relevant to pending INDs or PLAs. The meeting will be held at the Silver Spring, Md. Holiday Inn